Pay in 4 interest-free payments of $30.00 Learn more
Ships within 48 hours · Estimated delivery Jul 26 - Jul 31
WZ8040 is a novel mutant-selective irreversible EGFRT790M inhibitor with potential anticancer activity
InChi: InChI=1S/C59H109N6O19P
which displays high binding affinity for the cloned rat sst5 receptor In vitro: BIM 23052 and the CGP 23996-like compounds bind selectively to rat SSTR5 versus human SSTR1
flexneri strain expressing ArfA and deleted for ssrA
ClH/c1-3-24-18(23)21-12-8-15(9-13-21)19-10-11-20-17(22)16-7-5-4-6-14(16)2
Vibunazole (BAY-N-7133) n-16 17-diol WZ8040 is a novel mutant-selectiveVibunazole is a new antifungal azole. Vibunazole is an antifungal azole. Low concentrations of all three drugs inhibit Coccidioides immitis, strain Silveira, in vitro with a descending order of activity ketoconazole>Vibunazole>BAY 1 9139. The untreated, infected mice lost weight initially and progressively, whereas treated mice gain weight after an initial loss with Vibunazole (all doses), BAY 1 9139 and ketoconazole at 2. 5 mg kg day. With both